NYU Sues Pfizer Over Royalties For Cancer Drug Xalkori

Law360, New York (October 17, 2013, 8:15 PM ET) -- New York University on Wednesday slapped Pfizer Inc. with a breach of contract suit for allegedly failing to pay promised royalties on a cancer medicine the school says it was instrumental in developing, a charge the drugmaker called unfounded and vowed to fight.

The complaint, filed in New York state court, hinges on an arrangement the college inked more than two decades ago with California pharmaceutical company Sugen Inc. That business was founded by one of the university’s researchers and later acquired by Pharmacia & Upjohn...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers